短期课程*

SUNDAY, APRIL 29
MORNING, 10:00 am - 1:00 pm

SC1: Preclinical and Clinical Assessment of Immunogenicity: Multidomain Therapeutics and New Modalities, Including Gene Therapy and CAR T

Darshana Jani, MS, Senior Manager, Pfizer, Inc.

Seema Kumar, PhD, Associate Director, Quantitative Pharmacology & Drug Disposition (QPD), R&D Global Early Development (GED), EMD Serono, a business of Merck KGaA, Darmstadt, Germany

Magdalena Tary-Lehmann, MD, PhD, CSO, Cellular Technology Limited (CTL); Adjunct Associate Professor of Pathology, Case Western Reserve University (CWRU)

Ravi Shankar Singh, PhD, Associate Director, Clinical Pharmacology, Pfizer

Ben Hock, PhD, Director, Immunogenicity, BioMarin Pharmaceuticals

SC2: Translational Considerations for Development of Monoclonal Antibodies and Emerging Constructs: Part I: Focus on Construct Design

Glareh Azadi, PhD, Senior Scientist, Translational PKPD, Merck Research Laboratories


Gadi Bornstein, PhD, Senior Director, Biologics Discovery, TESARO, Inc.


Veronica Juan, PhD, Principal Scientist, Protein Sciences, Merck Research Labs


Scott L. Klakamp, PhD, Vice President of Chemistry and Biochemistry, Bioptix


Mohammad Tabrizi, PhD, Director Biologics Discovery, Merck Research Laboratories Palo Alto


SC3: The Life Science Executive's Fundraising Manifesto

Dennis Ford, Founder and CEO, Life Science Nation

SC4: Selection, Screening and Engineering for Affinity Reagents

Jonas Schaefer, PhD, Head, High-Throughput Binder Selection Facility, Biochemistry, University of Zurich

Christian Kunz, PhD., Associate Director, MorphoSys AG


AFTERNOON, 2:00 - 5:00 pm

SC5: In silico Immunogenicity Predictions (Hands-On) Workshop

Vinodh B. Kurella, PhD, Senior Scientist, Protein Engineering, Immuno-Oncology Division, Intrexon Corp.

SC6: Practical Considerations for Biomarker Bioanalysis

Darshana Jani, MS, Senior Manager, Pfizer, Inc.

Paul Rhyne, PhD., VP, Biological Development Services

Kelly Doering, PhD., DMPK Business Manager, Pharmaceutical Business, Waters

SC7: Translational Considerations for Development of Monoclonal Antibodies and Emerging Constructs: Part 2: Focus on Preclinical Development

Glareh Azadi, PhD, Senior Scientist, Translational PKPD, Merck Research Laboratories


Gadi Bornstein, PhD, Senior Director, Biologics Discovery, TESARO, Inc.


Veronica Juan, PhD, Principal Scientist, Protein Sciences, Merck Research Labs


Scott L. Klakamp, PhD, Vice President, Chemistry and Biochemistry, Bioptix


Mohammad Tabrizi, PhD, Director, Biologics Discovery, Merck Research Laboratories Palo Alto



TUESDAY, MAY 1
DINNER, 6:00 - 8:30 pm

SC8: Introduction to Biophysical Analysis for Biotherapeutics: Discovery & Development Applications

Christine P. Chan, PhD, Principal Scientist, Global Manufacturing Science & Technology, Sanofi


SC9: CAR T Cell Therapy for Solid Tumors

Soldano Ferrone, MD, PhD, Division of Surgical Oncology, Surgery, Massachusetts General Hospital, Harvard Medical School

Moonsoo M. Jin, PhD, Associate Professor, Molecular Imaging Innovations Institute, Radiology, Weill Cornell Medical College

Tara Arvedson, PhD, Director, Oncology Research, Amgen


THURSDAY, MAY 3
DINNER, 5:45 - 8:15 pm

SC10: Critical Considerations for the Design and Development of Antibody-Drug Conjugates

Isabel Figueroa, PhD, Scientist, PTPK, Genentech, Inc.

Shawn Owen, PhD, Assistant Professor, Pharmaceutics and Pharmaceutical Chemistry, University of Utah

SC11: Strategic/Modular Bioassay Design and Analysis

David Lansky, PhD, President, Precision Bioassay, Inc.

SC13: Sub Visible Protein Particles in Immunogenicity: Measurement, Characterization and Impact

Bjorn Boll, PhD, Head, Particle Lab and Higher Order Structure Protein Analytics, Physical Chemical Analytics, Novartis Pharma AG

Anacelia Rios Quiroz, PhD, Scientist, Group Leader Particle Lab, Pharma Technical Development Europe (Biologics) Analytics (PTDE-A), F. Hoffmann-La Roche Ltd.


DINNER, 5:45 - 8:45 pm

SC12: Transient Protein Production in Mammalian Cells

Richard Altman, MS, Scientist, Protein Technologies, Amgen

Henry C. Chiou, PhD, Associate Director, Cell Biology, Life Science Solutions, Thermo Fisher Scientific


*Separate registration required for Short Courses.

 

* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English

目录下载
Catalog
Premier Sponsors

Harbour Biomed

 LONZA tagline

Pall Life Sciences

Precision for Medicine 

赞助商

媒体合作夥伴